Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore professional investment ideas sourced from institutional letters, short theses, and premium research channels, distilled into concise summaries.
| Pitch Type | Author | Industry | Pitch Thesis & Key Summary | Bull/Bear | Action | ||
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | Fund Letter | Chad MeadeMeridian Small Cap Growth Fund | Veracyte Inc $VCYT• NASDAQ | Life Sciences Tools & ServicesLife Sciences Tools & Services | Meridian Small Cap Growth Fund - VCYT Veracyte, Inc. (VCYT) is a profitable genomic diagnostics company anchored by its Decipher prostate cancer test and Afirma thyroid test, supported by a deep base of proprietary clinical evidence. We own it... | NEUTRAL | View Pitch → |
| Aug 21, 2026 | Fund Letter | Chad MeadeMeridian Small Cap Growth Fund | Veracyte Inc $VCYT• NASDAQ | Life Sciences Tools & ServicesLife Sciences Tools & Services | Long VCYT (Veracyte, Inc.) Veracyte is a cancer diagnostics developer whose shares dropped following news of potentially ending funding for its loss-making French subsidiary. The manager considers... | BULL | View Pitch → |
Join institutional and professional investors receiving our weekly analysis of hedge fund letters, market trends, and high-conviction ideas.
Zero Spam • High Alpha • Unsubscribe Anytime
Investment pitches and theses displayed on Buyside Digest are summaries of opinions expressed in publicly available investor letters, research reports, or other commentary. These summaries are generated for informational and research purposes only and do not constitute investment recommendations, financial advice, or an endorsement of any particular security or strategy by Buyside Digest. Users should conduct their own independent due diligence and consult with professional advisors before making any investment decisions.